SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
SELLAS Life Sciences Gr第四季度每股收益（0.25）未达到预期（0.21）美元
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 41.86 percent increase over losses of $(0.43) per share from the same period last year.
SELLAS Life Sciences Gr（纳斯达克股票代码：SLS）公布的季度亏损为每股0.25美元，比分析师普遍预期的0.21美元（0.21美元）低19.05％。与去年同期每股亏损0.43美元（0.43）相比，增长了41.86％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。